Breast Cancer Research -- Einstein Researcher Dr. Susan Horowitz Awarded $250,000 by National Foundation For Cancer Research to Develop Novel Drugs to Overcome TaxolÒ Resistance

Bethesda, MD April 29, 2004 -- The National Foundation For Cancer Research has awarded a $250,000 grant and named Albert Einstein College of Medicine researcher, Dr. Susan Horwitz to its highest distinction, NFCR Fellow. The honor allows Dr. Horwitz flexibility and capability to explore scientific research over the next five years that will improve treatment options for patients who have failed cancer chemotherapy.

"Dr. Horwitz's breast cancer research has made major contributions to understanding cancer, and its interactions with TaxolÒ and other drugs currently on the market," said Franklin Salisbury, Jr., president of NFCR. "Her research has already led to many clinical applications and treatments of cancer patients today and she is a true example of how research in the laboratory translates into patient treatments."

Dr. Horwitz's research to develop new drugs that are active in human tumors and have become resistant to Taxol is groundbreaking. The introduction of Taxol and Taxotere in the 1990's was an important advance in treating women with breast and ovarian cancer. Later, it was discovered that some tumors are inherently resistant to these drugs and the presence of inherent drug resistance and the development of clinical resistance poses a major obstacle for the survival of cancer patients.

"Throughout her long career at Einstein, Dr. Horwitz has led by example, with achievements that are admirable and monumental," said Dr. Dominick P. Purpura, the Marilyn and Stanley H. Katz Dean at Einstein. "We are, indeed, pleased and proud of this wonderful honor that has been bestowed upon Susan by one of America's leading cancer organizations the National Foundation For Cancer Research."

"I am truly delighted to be named an NFCR Fellow and very appreciative for the support, both scientific and monetary, that the foundation has provided throughout its 30-year history. Its dedication to cancer researchers has led to many important discoveries that have improved our ability to help cancer patients," said Dr. Horowitz.

About NFCR
Since its founding in 1973, the National Foundation for Cancer Research has spent more than $200 million funding basic science cancer research and public education initiatives. For more information visit NFCR at www.NFCR.org or call (800) 321-CURE.




This article courtesy of http://www.doyouhavemesothelioma.com.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

Did you find what you are looking for? If NOT.. Try google.

Submit Your Article